Provided by Tiger Trade Technology Pte. Ltd.

Regeneron Pharmaceuticals

820.58
+21.502.69%
Volume:355.30K
Turnover:289.61M
Market Cap:84.48B
PE:20.29
High:822.48
Open:808.86
Low:804.32
Close:799.08
52wk High:847.00
52wk Low:541.00
Shares:102.95M
Float Shares:98.88M
Volume Ratio:0.67
T/O Rate:0.36%
Dividend:3.64
Dividend Rate:0.44%
EPS(TTM):40.43
EPS(LYR):41.48
ROE:14.04%
ROA:6.53%
PB:2.66
PE(LYR):19.78

Loading ...

Regeneron price target raised to $795 from $750 at Cantor Fitzgerald

TIPRANKS
·
Jul 31

AbbVie Beats Q2 Revenue, Adjusted EPS Estimates but Cuts FY Adj EPS Guidance

Reuters
·
Jul 31

Moderna Posts Smaller-than-expected Q2 Loss Per Share on Lower R&D Spending

Reuters
·
Jul 31

Regeneron Awards $150,000 to Winners of the 2026 Regeneron Prize for Creative Innovation

GlobeNewswire
·
Jul 31

Morgan Stanley Adjusts PT on Regeneron Pharmaceuticals to $758 From $730, Keeps Equalweight Rating

MT Newswires Live
·
Jul 31

Regeneron Pharmaceuticals Inc : JP Morgan Raises Target Price to $900 from $850

THOMSON REUTERS
·
Jul 31

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 31

Dexcom Q2 Revenue Beats Estimates Raises Outlook; Raises FY Revenue and Margin Guidance

Reuters
·
Jul 31

Stock Track | Regeneron Pharmaceuticals Soars 5.79% in Intraday Trading After Q2 Earnings Crush Estimates on Dupixent and Eylea HD Strength

Stock Track
·
Jul 31

Regeneron Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 31

U.S. Stocks on the MOVE-Mastercard, Starbucks, Meta

Reuters
·
Jul 30

Movement Alert|Regeneron Pharmaceuticals Rises 3.19% in Regular Trading, Q2 Earnings Massively Beat Expectations

Market Focus
·
Jul 30

Regeneron Pharmaceuticals Shares up 1% After Upbeat Q2 Results

THOMSON REUTERS
·
Jul 30

Sanofi Expects Moderate Increases in R&D Spend

Reuters
·
Jul 30

Regeneron Publishes Corporate Presentation Highlighting Q2 Pipeline Progress and Product Sales Trends

Reuters
·
Jul 30

Regeneron Beats Quarterly Estimates on Eczema Drug Strength, Shares Rise

Reuters
·
Jul 30

U.S. Stocks on the MOVE-Fortinet, Regeneron, Cigna

Reuters
·
Jul 30

Sanofi CEO, on Regeneron Partnership, Says Co's Main Objective Has Been to Rebuild Trust

THOMSON REUTERS
·
Jul 30

Drug Maker Regeneron Gains After Upbeat Q2 Results

Reuters
·
Jul 30

Regeneron Posts Higher 2Q Revenue, Sees Improving Profit

Dow Jones
·
Jul 30